Part of Inizio, market-leading commercialization platform, Inizio Ignite is the global advisory partner for health and life sciences. Guided by purpose, passion, and precision, our people collaborate with clients to ignite impact, accelerate performance, and deliver lasting change for patients. By uniting strategy, insights, and innovation with a unique depth and breadth of expertise, we drive transformation and shape the future of health.
As a consulting firm with deep expertise in both generative AI and business strategy, we support leading pharmaceutical companies in developing and deploying AI agents. Our specialized team—with strong industry knowledge—works end-to-end across clinical research analysis, manufacturing quality management, and HCP engagement to deliver real, scalable impact.
ADVANCE®AI is the global field execution benchmarking company, with its own proprietary AI native algorithms. ADVANCE®AI enables organisations to quantify and benchmark the quality & alignment of HCP engagements across field medical, commercial and market access/reimbursement. Trusted by pharmaceutical companies worldwide including 8 of the top 10, it owns the world's only proprietary AI field observation benchmark database, together with APEX*, the world’s only pharma specific sentiment score with an almost perfect correlation to sales growth, built in collaboration with 15 pharma companies. ADVANCE®AI helps pharma make data-driven decisions with proven RoI, delivering circa 15-20% additional growth within a year.
IBM is a leading global hybrid cloud and AI, and business services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity, and service.
PharmaForceIQ is a real-time engagement platform built for life sciences, giving you an unfair advantage in engaging the right HCPs and patients. Our platform unites deep affinity data for 7M+ HCPs, streamlined optichannel execution across 75K+ sites/platforms, and live Rx-level reporting to maximize spend. We update targeting and deployment dynamically, so you never miss a moment that matters, and that has earned us a 100% client renewal rate. Experience the power of true agility: launch on the optimal mix for your audience, optimize campaigns mid-flight, sync with the field effectively, and prove impact fast.
Celebrating its 25th anniversary in 2026, Real Chemistry is a tier one healthcare communications partner to the world’s most innovative life sciences and healthcare companies. As a leading provider of AI-powered audience insights, Real Chemistry helps the healthcare industry better understand, reach, and engage critical audiences to improve the healthcare experience for all. Real Chemistry’s 2,000+ global experts across life sciences, marketing communications, and technology are singularly focused on navigating the complexities of bringing scientific advances to market—and to the people who need them most. Real Chemistry’s brand portfolio includes the highly awarded creative agency 21GRAMS and its celebrity and influencer practice, starpower.
Real Chemistry – the largest independent agency focused solely on healthcare marketing and communications – operates through wholly owned offices across North America, Europe, and the Middle East, complemented by a strategic partner network in Asia Pacific, Latin America, and Africa—enabling the company to support clients worldwide.
Impiricus is the first and only AI-powered HCP Engagement Engine. Founded by a practicing physician and a senior pharmaceutical executive, Impiricus was created to transform how life sciences companies support physicians. We ethically connect HCPs to pharma resources, reduce go-to-market costs and accelerate patient access to the treatments they need.
With our unique access to the largest opted-in network of HCPs, their insights, and clinical expertise, we are the leading provider of AI technology and real-time channels that life science companies need to deliver clear, reliable, and evidence-based resources directly into the hands of HCPs.
Guided by a council of 2000+ trusted HCP advisors, we ensure every interaction is clinically meaningful, ethically grounded and leads to better patient care.
WellSky is one of America’s largest and most innovative healthcare technology companies, leading the movement for intelligent, coordinated care. In today’s value-based care environment, WellSky connects providers, payers, health systems, life sciences companies, and community organizations through AI-powered software, analytics, and services.
Diaceutics is the intelligence and engagement company unlocking the full potential of diagnostic-driven therapies. We help biopharma teams find eligible patients earlier, understand where diagnostic pathways break down and act while treatment decisions are still forming. Powered by proprietary, near-real-time diagnostic data, AI-enabled technology and commercialization expertise, we turn complex pathway signals into coordinated action. Supporting more than 700 therapies, Diaceutics helps close the gap between scientific innovation and what patients experience in the real world.
uMed is a healthcare evidence-generation technology company addressing the critical evidence gaps needed to accelerate the delivery of new medicines and innovations to patients. Through its ACCESS Research Platform, embedded across a growing network of healthcare institutions in the UK and US, uMed enables researchers to rapidly engage patients and generate insights from the decentralised collection of electronic health records, clinical outcomes, patient-reported data, and biosamples. uMed was founded by Dr Matt Wilson, an NHS doctor and anaesthesiologist, and works with leading pharmaceutical companies and academic researchers worldwide.
ODAIA helps pharma commercial teams identify which HCPs have the greatest opportunity today and where each is in their journey, then automatically sequences and orchestrates personalized engagement across digital and field.
Using real-time HCP and patient signals, ODAIA moves pharma beyond static target lists and broad segments to N=1 HCP engagement that continuously adapts as market opportunity and HCP behaviors change.Â
Proxima Research is an international healthcare technology company with more than 30 years of expertise, providing data, technology, and services across 40+ countries. Our flagship product, Proxima Cloud CRM, is a purpose-built platform for pharmaceutical commercial teams, unifying field force management, HCP engagement, omnichannel communications, compliance tracking, and analytics. Designed to adapt to unique business KPIs, it gives commercial leaders greater visibility into field performance while reducing administrative workload through AI-powered capabilities such as predictive territory alignment. Available through AWS Marketplace, Proxima Cloud CRM also enables faster infrastructure provisioning and deployment.
ProclaimRx is an award-winning AI data integration and intelligence platform purpose-built for life sciences. Founded by pharma and AI veterans, ProclaimRx empowers commercial, marketing, and medical affairs teams to maximize revenue and execute strategy with certainty. From launch to maturity, ProclaimRx puts the full power of your data at your fingertips. Our advanced AI intelligence engine unifies fragmented commercial data, transforming chaotic data streams into fast, trusted answers to your most complex business questions. And with predictive modeling, media mix modeling (MMM) scenarios, and prescriptive recommendations, you can move beyond understanding what happened to controlling what happens next.
The Healthcare Businesswomen’s Association is a global nonprofit organization comprised of individuals and organizations in healthcare committed to:
achieving gender parity in leadership positions
providing equitable practices that enable organizations to realize the full potential of women
facilitating career and business connections to accelerate advancement
The HBA accomplishes its mission through strong business networks, education, research, advocacy, and recognition of individuals and companies.
